Products
Gliconorm™
Product Information
Gliconorm™ is a second line therapy to treat non-insulin dependent diabetes mellitus (NIDDM). This fixed dose in one tablet provides convenience for patients and helps increase patient compliance. Description
Gliconorm is a film-coated, divisible tablet which contains a fixed dose of glibenclamide (5 mg) and metformin (500 mg). Active Substance
Glibenclamide, Metformin. Strengths
Glibenclamide 5mg + Metformin 500mg. Indication
Gliconorm™ is a second line therapy to treat non-insulin dependent diabetes mellitus (NIDDM) that cannot be satisfactorily controlled with diet alone, diet plus a sulfonylurea, or diet plus metformin. Regulatory Status
Approved in Italy, Last revised: Nov 2007. Currently under registration in the AfMET region. 
|